Vb. Schinikerth et al., N-ALPHA-TOSYL-L-LYSINE CHLOROMETHYLKETONE PREVENTS EXPRESSION OF INOSIN VASCULAR SMOOTH-MUSCLE BY BLOCKING ACTIVATION OF NF-KAPPA-B, Arteriosclerosis, thrombosis, and vascular biology, 17(4), 1997, pp. 672-679
Certain cytokines and lipopolysaccharide stimulate expression of induc
ible nitric oxide synthase (iNOS) in vascular smooth muscle, an event
that is regulated at the transcriptional level and appears to involve
several transcription factors, including nuclear factor kappa B (NF-ka
ppa B). Since proteases play an essential role in NF-kappa B activatio
n, experiments were designed to clarify, in both cultured rat aortic s
mooth muscle cells (SMCs) and isolated rat aortas, whether protease in
hibitors affect the interleukin-1 beta (IL-1 beta)-elicited expression
of iNOS. The formation of NO was assessed by nitrite release in cultu
red SMCs and the attenuation of phenylephrine-induced contraction in a
ortic rings, the expression of iNOS by Western blot analysis and rever
se transcription-polymerase chain reaction, and NF-kappa B activity in
nuclear extracts by gel electrophoretic mobility shift assay. Exposur
e of cultured SMCs to IL-1 beta increased NF-kappa B binding activity
within 30 minutes and was associated with nitrite accumulation and the
appearance of iNOS protein 24 hours later. These responses were aboli
shed in cells that had been exposed to the cytokine in the presence of
the protease inhibitor N-alpha-tosyl-L-lysine chloromethylketone. Apr
otinin and p-toluenesulfonyl-L-arginine methyl ester, two other protea
se inhibitors, also reduced the cytokine-stimulated release of nitrite
and the level of iNOS protein. Exposure of rat aortic segments withou
t endothelium to IL-1 beta activated NF-kappa B within 30 minutes and
was associated with the appearance of iNOS mRNA and an attenuation of
phenylephrine-induced contraction 6 hours later. These responses were
blunted when the segments were incubated with the cytokine and N-alpha
-tosyl-L-lysine chloromethyl ketone. The present observations indicate
that protease inhibitors prevent iNOS expression in both cultured and
native vascular SMCs by blocking the activation of NF-kappa B.